Deutsche Bank's U.S. Unit Clears Second Round Of Stress Test

 | Jun 27, 2019 10:01PM ET

Beleaguered by litigation issues, dismal performance and regulatory probes over the past few months, Deutsche Bank (DE:DBKGn) (NYSE:DB) got a boost from the Federal Reserve’s approval to its capital plan. The bank’s U.S. subsidiary, DB USA Corporation (“DBUSA”), cleared the second level of the Fed’s stress test 2019, which allowed the German lender to increase investors’ payouts.

Deutsche Bank’s clearance of the annual stress test conducted by the Fed to determine that the banking giants are adequately capitalized to survive under a tremendously difficult economic scenario and a subsequent capital plan approval lend a ray of hope to the CEO Christian Sewing in implementing its turnaround strategies. However, the plans got delayed due to the rising concerns over the health of the bank’s U.S. operations.

"This is excellent news," Sewing told employees in a memo published late Thursday. "Achieving success here was one of the key goals we set a year ago. And it is a huge step forward for our business in the US and globally. A strong operating platform in the Americas is essential to our clients."

The Fed concluded that even in an adverse economic condition, DBUSA’s Common Equity Tier 1 capital would remain above the minimum requirement of 4.5% and would not fall below 14.8% over the nine-quarter planning horizon.

Notably, DBUSA’s capital scheme was rejected by the Fed last year on account of “widespread and critical deficiencies” in its capital planning. Also, the reviewer found weakness in data capabilities and controls that contributed to DBUSA’s capital planning process.

The stress test results bear a testimony to Deutsche Bank’s status. Meanwhile, shares of the company have declined around 29% on the NYSE in the past year, due to a number of factors including worries over balance sheet, business operations, costs-control measures and failed merger talks with Commerzbank AG (DE:CBKG).